Company for sale
- Sales: < 10 million
- Location: Europe
- Reason for sale: The owners are looking for a strategic partner to help the company expand
- #CFIE PHS149
Overview of injectable drug manufacturer in Europe for sale
The company is an established manufacturer of injectable drugs. Further, it has a good regulatory track record and produces high-quality/low-cost products in multiple pharmaceutical forms. Currently, the company is seeking a strategic buyer to improve margins and expand its product portfolio.
Contact us to get details about this injectable drugs manufacturer in Europe for sale
Profile (strategy) of injectable drug manufacturer in Europe for sale
Primarily, the company is an established manufacturer of injectable drugs. In addition, it has a good regulatory track record and produces high-quality/low-cost products in multiple pharmaceutical forms. At this time, the company’s European site is being mothballed, and the company is seeking a strategic buyer to improve margins.
In general, the company produces cytotoxics and other injectable drugs. In particular, these products are available in solutions and freeze-dried forms. These are then packaged in vials, ampoules, and pre-filled syringes. Also, the company produces small and large liquid volumes (up to 100 ml).
Now, the company has a single site in the EU with a total area of more than 300,000 square meters. More specifically, the site has four plants, six manufacturing lines, and fully automated control of vials and ampoules. Critically, the site also has a GMP chemical laboratory, a GMP microbiological laboratory, warehousing for finished and semi-finished products, and a worldwide distribution network. Furthermore, the company distributes its products worldwide, with a focus on Europe and Japan. Notably the company has a broad portfolio of products, including the highest quality generics and established brands.
Strategically, the company has a well-maintained infrastructure, with several hundred employees and a service-driven culture. Of equal importance, the company is committed to operational excellence, continuous improvement, regulatory compliance, and EHS (environmental, health, and safety).
Curious about your company’s market value?
Use the link provided to access our valuation tool
Activities and products of injectable drug manufacturer in Europe for sale
Altogether, the company is a good investment opportunity for a strategic buyer. Positively, the buyer has the opportunity to acquire a reputable plant in the industry with more than 100 strong and skilled professionals. Besides this, the buyer will also benefit from the company’s state-of-the-art equipment and European fill-and-finish capabilities. Above all, the company produces cytotoxics and other injectable drugs that are available in solutions and freeze-dried forms. These are packaged in vials, ampoules, and pre-filled syringes. As well as this, the company also produces small and large liquid volumes (up to 100 ml).
Highlights of injectable drug manufacturer in Europe for sale
- Established manufacturing capabilities for injectable drugs
- Highly potent drug-handling
- Excellent regulatory track record
- High-quality/low-cost products
- Multiple pharmaceutical forms
More information on this injectable drug manufacturer in Europe for sale
Please get in touch if you are interested in learning more about this injectable drug manufacturer in Europe for sale. For more pharma manufacturer companies for sale please visit the section pharma manufacturer companies for sale. For other pharma manufacturer buyers, please visit the section pharma manufacturer companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.